Literature DB >> 14622090

Co-activation of PKA and PKC in cerebrocortical nerve terminals synergistically facilitates glutamate release.

Carmelo Millán1, Magdalena Torres, José Sánchez-Prieto.   

Abstract

Protein kinase A and protein kinase C are involved in processes that enhance glutamate release at glutamatergic nerve terminals. However, it is not known whether these two kinases co-exist within the same nerve terminal, nor is it clear what impact their simultaneous activation may have on neurotransmitter release. In cerebrocortical nerve terminals, co-application of forskolin, which increases cAMP levels and activates protein kinase A, and 4beta-phorbol dibutyrate, a direct activator of protein kinase C, synergistically enhanced the spontaneous release of glutamate. This enhancement exhibited both tetrodotoxin-sensitive and tetrodotoxin-resistant components. Interestingly, the tetrodotoxin-resistant component of release was not observed when cyclic AMP-dependent protein kinase (PKA) and calcium- and phospholipid-dependent protein kinase (PKC) were activated separately, but developed slowly after the co-activation of the two kinases, accounting for 50% of the facilitated release. This release component was dependent on voltage-dependent Ca2+ channels that opened spontaneously after PKA and PKC activation and occurred in the absence of Na+ channel firing. These data provide functional evidence for the co-existence of PKA- and PKC-signalling pathways in a subpopulation of glutamatergic nerve terminals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622090     DOI: 10.1046/j.1471-4159.2003.02065.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  Idebenone inhibition of glutamate release from rat cerebral cortex nerve endings by suppression of voltage-dependent calcium influx and protein kinase A.

Authors:  Yi Chang; Yu-Wan Lin; Su-Jane Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-04       Impact factor: 3.000

2.  β-Adrenergic receptors activate exchange protein directly activated by cAMP (Epac), translocate Munc13-1, and enhance the Rab3A-RIM1α interaction to potentiate glutamate release at cerebrocortical nerve terminals.

Authors:  Jose J Ferrero; Ana M Alvarez; Jorge Ramírez-Franco; María C Godino; David Bartolomé-Martín; Carolina Aguado; Magdalena Torres; Rafael Luján; Francisco Ciruela; José Sánchez-Prieto
Journal:  J Biol Chem       Date:  2013-09-13       Impact factor: 5.157

Review 3.  Estrogen receptors' neuroprotective effect against glutamate-induced neurotoxicity.

Authors:  Yu-Long Lan; Jie Zhao; Shao Li
Journal:  Neurol Sci       Date:  2014-09-17       Impact factor: 3.307

4.  Inhibiting spinal secretory phospholipase A2 after painful nerve root injury attenuates established pain and spinal neuronal hyperexcitability by altering spinal glutamatergic signaling.

Authors:  Sonia Kartha; Prabesh Ghimire; Beth A Winkelstein
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

5.  Inhibition of Glutamate Release from Rat Cortical Nerve Terminals by Dehydrocorydaline, an Alkaloid from Corydalis yanhusuo.

Authors:  Tzu-Yu Lin; I-Yen Chen; Ming-Yi Lee; Cheng-Wei Lu; Kuan-Ming Chiu; Su-Jane Wang
Journal:  Molecules       Date:  2022-01-31       Impact factor: 4.411

6.  Palmitoylethanolamide inhibits glutamate release in rat cerebrocortical nerve terminals.

Authors:  Tzu-Yu Lin; Cheng-Wei Lu; Chia-Chan Wu; Shu-Kuei Huang; Su-Jane Wang
Journal:  Int J Mol Sci       Date:  2015-03-11       Impact factor: 5.923

7.  Analysis of protein phosphorylation in nerve terminal reveals extensive changes in active zone proteins upon exocytosis.

Authors:  Mahdokht Kohansal-Nodehi; John Je Chua; Henning Urlaub; Reinhard Jahn; Dominika Czernik
Journal:  Elife       Date:  2016-04-26       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.